Award-winning actor and producer Sterling K. Brown joins Bristol-Myers Squibb in effort to share stories of What It's Like to Live with Cancer Today

Bristol-Myers SquibbTwo-time Emmy Award winner Sterling K. Brown (This Is Us, Black Panther) is partnering with Bristol-Myers Squibb on a series designed to illuminate the triumphs and challenges of life after a cancer diagnosis. Survivorship Today: What It's Like to Live with Cancer explores the stories of people who have experienced lasting physical, emotional and social effects from cancer to build greater understanding of, and draw attention to, survivorship-related issues.

Today, more people who have been diagnosed with cancer are able to live with the disease than ever before. During this time of rapid progress in cancer treatment, researchers are only just beginning to understand the long-term impacts of the disease on individuals and their loved ones. As the number of cancer survivors in the United States (U.S.) grows to nearly 17 million this year, it is increasingly important to recognize and address the current realities of cancer survivorship. Brown, who lost his uncle to cancer, is speaking with people around the country who have been impacted by the disease to find out what it's like to live with cancer today.

"When my uncle, Sonny, passed away from cancer just six months after his diagnosis, my entire family was devastated. Now, 15 years later, many people with cancer are living longer," said Brown. "While that means they might have a chance to celebrate another birthday or watch their children have children, it also means their lives have likely been forever changed. Survivorship Today will bring these experiences to light to show the long-term effects of cancer, with the goal of helping people feel supported every step of their journey."

Through the stories of people affected by cancer, the series will delve into topics such as:

  • Overcoming barriers: Some people who are diagnosed with cancer face a greater burden of the disease due to their unique circumstances, whether at home, at work or in their communities, which can affect them from diagnosis through treatment and beyond.
  • Impact on emotional and mental health: A person diagnosed with cancer is twice as likely to experience mental health problems compared to a person without the disease. These impacts can be even greater for individuals diagnosed as a young adult and can persist long after treatment ends.
  • Relationships afterward: Cancer touches all those who care about the person living with the disease. It deeply affects friends and family on emotional and physical levels as they do their best to support their loved one over time.

"Living long-term with cancer is a relatively new idea. We've made tremendous progress in addressing the disease itself, but we still need to answer the question of what comes next, outside of treatment," said Adam Lenkowsky, Head of U.S. Oncology, Bristol-Myers Squibb. "By bringing cancer survivorship into greater focus with this series, our goal is to help start a dialogue on the realities of living with cancer, so we can work together toward a day when all people with cancer can live longer, healthier lives and get the support they need."

Watch the series at SurvivorshipToday.com.

About Survivorship Today

Survivorship Today: What It's Like to Live with Cancer is an initiative by Bristol-Myers Squibb that, through the stories of people living with cancer, aims to advance our understanding of what it's like to live with the disease today and inspire action to provide better support.

About Cancer Survivorship

Cancer survivorship refers to the time from diagnosis throughout the remainder of a person’s life. There are nearly 17 million cancer survivors in the U.S. today. Over the next 10 years, this number is projected to increase to nearly 22 million. Today, more than 67 percent of people living with cancer have been alive for at least five years after their initial diagnosis, and more than 45 percent of people have been alive 10 years after diagnosis. However, many people living with cancer feel unprepared for life after active treatment.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Most Popular Now

Aspirin green light for brain bleed stroke patient…

People who suffer a stroke caused by bleeding in the brain - known as brain haemorrhage - can take common medicines without raising their risk of another stroke, a major ...

Cancer cells are quick-change artists adapting to …

Until now, researchers have assumed that the growth of solid tumors originates from cancer stem cells characterized by specific surface markers, which develop in a fixed...

APRINOIA Therapeutics awarded grant from The Micha…

APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that...

Benralizumab not effective reducing exacerbations …

More than 15.3 million people in the U.S. suffer from chronic obstructive pulmonary disease (COPD), which is the third leading cause of death in this country, according t...

Pfizer announces top-line results from Phase 3 Tri…

Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin) as adjunctive therapy for epilepsy patients 5 to 65 years of age wi...

Novartis phase II data for new inhaled combination…

Novartis announced today that new phase II data for IND/GLY/MF (QVM149), an investigational, once-daily, fixed dose combination asthma treatment containing indacaterol ac...

New data show Symbicort reduces attacks in mild as…

New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol)...

Cannabis use among older adults rising rapidly

Cannabis use among older adults is growing faster than any other age group but many report barriers to getting medical marijuana, a lack of communication with their docto...

Merck pioneers new effort to see MS from the insid…

Merck, a leading science and technology company, joins the global multiple sclerosis (MS) community in recognition of World MS Day, an initiative created by the Multiple ...

Amgen joins with community oncology networks for n…

Amgen (NASDAQ: AMGN), along with leading community oncology networks, today announced the launch of Amgen Community Oncology Research Collaborators (ACORC), a new initiat...

Bayer receives U.S. FDA breakthrough therapy desig…

Bayer announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for copanlisib (Aliqopa™) for the treatment of adult patie...

Roche's personalised medicine entrectinib shrank t…

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced positive data from the Phase I/II STARTRK-NG study, evaluating the investigational medicine entrectinib in children and adole...